Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000237

Drug Information
SynonymsEmotion; Equitam; Lorafen; Lorazep; Lorazepam Fabra; Nervistopl; Loraz; Lorazon; L1764_SIGMA; Lorenin; Lorazepam Medical; Lorat; Lorazepam Baxter Brand; Lorzem; WLN: T67 GMV JN IHJ CG IQ KR BG; Wyeth Brand of Lorazepam; ApoLorazepam; Lorivan; Idalprem; D008140; Tavor; o-Chlorooxazepam; Lorapam; Lorazepam Apotex Brand; Laubeel; Tranqipam; Lorazepam ratiopharm Brand; Alzapam; Lorazepam Riemser Brand; Lorazepam Desitin Brand; Lorazin; Tolid; 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-; Demethyllormetazepam; o-Chloroxazepam; Larpose; LS-34141; NSC 289758; Orfidal Wyeth; KBio1_000965; Pro dorm; Lomesta; lorazepam; Rocosgen; Durazolam; Lorazepam-Efeka; Temesta; Lorazepam (JP15/USP/INN); Lorazepam neuraxpharm; Lorazepamum [INN-Latin]; 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-; Aplacassee; Lorazepam preservative free; Apo Lorazepam; Merlit; NSC289758; Bonton; Aripax; Quait; Sedizepan; Baxter Brand of Lorazepam; Lorazepam Intensol; SAM001246833; Lorazepam-neuraxpharm; IDI1_000965; Donix; Punktyl; neuraxpharm Brand of Lorazepam; 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Duralozam; Sedicepan; Nu-Loraz; Medical, Lorazepam; Novolorazem; BRN 0759084; 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-, (+-)-; Nu Pharm Brand of Lorazepam; Loridem; AC1L1H3H; Novhepar; EINECS 212-687-6; 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one; lorazep von ct; Lorans; Wy 4036; (+/-)-Lorazepam; DivK1c_000965; Nu-Pharm Brand of Lorazepam; Novartis Brand of Lorazepam; Silence; 5-25-02-00248 (Beilstein Handbook Reference); (+-)-7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one; Lozepam; 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1H-1,4-benzodiazepin-2(3H)-one; Lorazepam Genericon; Anzepam; Kalmalin; Desitin Brand of Lorazepam; Lorazepam Novartis Brand; Novo Lorazem; NINDS_000965; Lorazepam Dolorgiet Brand; Wy-4036; HMS503A11; CPD000058410; Lorazepam neuraxpharm Brand; Medical Brand of Lorazepam; Lorazepamum; DEA No. 2885; ct Arzneimittel Brand of Lorazepam; Novopharm Brand of Lorazepam; DB00186; Nervistop L; ratiopharm Brand of Lorazepam; Norlormetazepam; Renaquil; Lopam; Wyeth, Orfidal; lorazepam (Ativan); Lorazepam Nu-Pharm Brand; nchembio747-comp26; Riemser Brand of Lorazepam; Llorens Brand of Lorazepam; Merck dura Brand of Lorazepam; Max Pax; Lorazepam Llorens Brand; Lorazepam Wyeth Brand; Lorazepam [USAN:INN:BAN:JAN]; UNII-O26FZP769L; 2H,1,4-Benzodiazepin-2-one, 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-; Anxiedin; D00365; Sinestron; Lorsilan; Sedazin; Ativan (TN); Emotival; NCGC00159439-02; HMS2052H07; Aplacasse; Anxira; Apotex Brand of Lorazepam; Lorazepam AHP Brand; 7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one; Upan; Lorazepam Novopharm Brand; Lorabenz; NuLoraz; Medix Brand of Lorazepam; ct-Arzneimittel Brand of Lorazepam; Loram; Bonatranquan; CID3958; Azurogen; Sedatival; 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one; Trapax; Nu Loraz; Orfidal; Vigiten; Serra Pamies Brand of Lorazepam; Sidenar; Delormetazepam; Stapam; Lorazepam Medix Brand; AHP Brand of Lorazepam; Almazine; Lorazepam-ratiopharm; Apo-Lorazepam; Efasedan; Lorazene; Lorsedal; Lorazepam ct-Arzneimittel Brand; MolPort-002-051-769; Lorazepam Lannacher; Lorazepan Richet; Lorazepam ratiopharm; Securit; 846-49-1; Wypax; CHEBI:116959; Somagerol; Novo-Lorazem; Lorazepan Chobet; Lorax; Lorazepam Medical Brand; Ativan; CHEMBL580; WY4036; Dolorgiet Brand of Lorazepam
Trade NameAtivan; Temesta
CompanyWyeth Pharmaceuticals
IndicationAnxiety disorder
[ICD9: 300   ICD10: F40-F42]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl    
Therapeutic ClassAnti-anxiety Agents
CAS NumberCAS 846-49-1
PubChem Compound IDCID 3958.
PubChem Substance IDSID 145006.
SuperDrug ATC IDN05BA06
SuperDrug CAS ID000846491;
TargetBenzodiazepine receptorAgonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071117 To Reference
Ref 2Differing effects of intracortical circuits on plasticity. Exp Brain Res. 2009 Mar;193(4):555-63. Epub 2008 Dec 2. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543